OXFORD IMMUNOTEC GLOBAL PLC's ticker is OXFD and the CUSIP is G6855A103. A total of 61 filers reported holding OXFORD IMMUNOTEC GLOBAL PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $619,000 | -49.9% | 48,500 | -36.4% | 0.04% | -39.4% |
Q3 2018 | $1,236,000 | -33.4% | 76,200 | -47.1% | 0.07% | -34.9% |
Q2 2018 | $1,857,000 | +50.2% | 144,100 | +45.1% | 0.11% | +38.0% |
Q1 2018 | $1,236,000 | +131.9% | 99,300 | +159.9% | 0.08% | +172.4% |
Q4 2017 | $533,000 | -62.7% | 38,200 | -55.1% | 0.03% | -62.3% |
Q3 2017 | $1,430,000 | -43.5% | 85,130 | -43.4% | 0.08% | -50.6% |
Q2 2017 | $2,531,000 | +8.6% | 150,500 | 0.0% | 0.16% | +6.1% |
Q1 2017 | $2,331,000 | +155.0% | 150,500 | +145.9% | 0.15% | +96.0% |
Q4 2016 | $914,000 | +85.4% | 61,200 | +55.7% | 0.08% | +87.5% |
Q3 2016 | $493,000 | +40.1% | 39,300 | +0.3% | 0.04% | +21.2% |
Q2 2016 | $352,000 | -32.6% | 39,200 | -25.6% | 0.03% | -37.7% |
Q1 2016 | $522,000 | -27.8% | 52,700 | -16.2% | 0.05% | -42.4% |
Q4 2015 | $723,000 | -3.7% | 62,900 | +12.7% | 0.09% | -6.1% |
Q3 2015 | $751,000 | +167.3% | 55,800 | +179.0% | 0.10% | +151.3% |
Q1 2015 | $281,000 | – | 20,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 1,695,888 | $15,704,000 | 7.12% |
First Light Asset Management, LLC | 4,050,040 | $37,503,000 | 6.40% |
Stonepine Capital Management, LLC | 374,431 | $3,467,000 | 3.67% |
Penn Capital Management Company, LLC | 941,579 | $8,724,000 | 1.44% |
Senvest Management, LLC | 1,325,854 | $12,277,000 | 1.44% |
Birchview Capital, LP | 170,303 | $1,577,000 | 1.40% |
Grandeur Peak Global Advisors, LLC | 1,391,318 | $12,884,000 | 1.39% |
HighMark Wealth Management LLC | 114,015 | $1,055,000 | 1.27% |
Consonance Capital Management LP | 1,244,460 | $11,524,000 | 0.86% |
Granahan Investment Management | 814,431 | $7,542,000 | 0.41% |